Financials data is unavailable for this security.
Cash flow in GBPView more
In 2023, cash reserves at Hemogenyx Pharmaceuticals PLC fell by 1.29m. Cash Flow from Financing totalled 4.45m or -- of revenues. In addition the company used 6.11m for operations while cash used for investing totalled 31.94k.
Cash flow per share | -0.0037 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0023 |
---|---|
Tangible book value per share | 0.0019 |
More ▼
Balance sheet in GBPView more
Current ratio | 4.38 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.9087 |
---|---|
Total debt/total capital | 0.4794 |
More ▼